Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeMerck

      Merck

      FDA Accepts Merck’s Filing for Sotatercept in PAH Treatment 
      Investing News

      FDA Accepts Merck’s Filing for Sotatercept in PAH Treatment 

      October 2, 2023
      Merck and Eisai’s Combination Therapy Fails in Two Lung Cancer Studies
      Investing News

      Merck and Eisai’s Combination Therapy Fails in Two Lung Cancer Studies

      September 25, 2023
      3M Vs. Merck: Which Dow Dividend Stock Offers Better Investment Opportunities?
      Trading Tips

      3M Vs. Merck: Which Dow Dividend Stock Offers Better Investment Opportunities?

      August 2, 2023
      Merck Stock Rose Slightly After Eisai and Merck Ended Two Keytruda Combo Studies After Missing Primary Targets
      Investing News

      Merck Stock Rose Slightly After Eisai and Merck Ended Two Keytruda Combo Studies After Missing Primary Targets

      April 7, 2023
      Merck Stock Went Down Even After the Company Reported Its Q4 Results
      Investing News

      Merck Stock Went Down Even After the Company Reported Its Q4 Results

      February 1, 2023
      Merck Stock Rose After Keytruda Met the Phase 3 Trial Survival Objective in Biliary Tract Cancer
      Investing News

      Merck Stock Rose After Keytruda Met the Phase 3 Trial Survival Objective in Biliary Tract Cancer

      January 25, 2023
      Merck Stock Was Upgraded to Buy at BOFA Despite the Risk Associated With Keytruda
      Trading Tips

      Merck Stock Was Upgraded to Buy at BOFA Despite the Risk Associated With Keytruda

      January 4, 2023
      Merck Stock Flattens as Ranked the Best-performing Major American Pharmaceutical in 2022
      Investing News

      Merck Stock Flattens as Ranked the Best-performing Major American Pharmaceutical in 2022

      December 30, 2022
      Merck Stock Went Up as It Relied on a New Formulation of Keytruda to Avoid a Patent Cliff
      Investing News

      Merck Stock Went Up as It Relied on a New Formulation of Keytruda to Avoid a Patent Cliff

      December 2, 2022
      Merck Beats Expectations for the Third Quarter as Sales of the COVID-19 Tablet Are Partially Offset by Keytruda
      Investing News

      Merck Beats Expectations for the Third Quarter as Sales of the COVID-19 Tablet Are Partially Offset by Keytruda

      October 27, 2022
      1 2 »

       

      LATEST NEWS

      • Investing News JPMorgan Q4 2025 Earnings Overview
      • Investing News As Netflix Drops 33%, Is NFLX Stock a Buy Ahead of Q4?
      • Investing News Will AAPL Stock Rebound in 2026?
      • Investing News Retail’s 2025 Holiday Growth
      • Investing News Goldman Sachs Earnings Lead Q1 Reports

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026